JUN 03, 2017 9:06 AM PDT

Why Does Fish Oil Stop Lupus?

WRITTEN BY: Xuan Pham

Sometimes scientists have to work in reverse. That is, they may know that a compound seems to treat a disease, but then they have to work backwards to understand exactly how the drug acts on the body. Such is the case with lupus and omega-3 fatty acid, or DHA. The compound is effective at stopping lupus, but not much is known about the why and the how. And scientists at Michigan State University intend on answering these questions with the $2.3 million grant from the National Institute of Health.

Image credit: pixabay.com

"Lupus is the body's immune system attacking itself and it can damage any part of the body including skin, joints and organs," explained Dr. James Pestka, a University Distinguished Professor of food science and human nutrition. "This new research will let us see what happens at the cellular level in the triggering of lupus and how we can intervene nutritionally with DHA to prevent the flaring and progression of the disease."

The disease affects an estimated 5 million people worldwide. Some forms of the disease have genetic underpinnings, and other forms are brought on by environmental stressors, like infections and exposure to certain medications. In particular, Pestka and his team are focused on the lupus associated with inhalation of silica, a toxic mineral. Several studies previously linked occupational exposure to crystalline silica and risk of developing systemic lupus erythematosus, the most common and serious form of the disease.

Previous research also show that this type of lupus seemed to be treatable with omega-3 fatty acids, also known as docosahexaenoic acid (DHA). This fat is found primarily in fish, and is often praised for its health benefits. Indeed, DHA has been linked to lowering the risk of heart disease, rheumatoid arthritis, and depression. The compound is even added to prenatal supplements as research shows it’s important for a baby’s visual and neurological developments.

"When lupus is triggered by fine inhalable particles called crystalline silica in the lungs, our earlier research has shown that DHA essentially stopped the activation of the disease," said Pestka.

Why is this the case? Some researchers hypothesize that DHA may signal the cells to ingest the toxic silica particles, and thereby preventing a systemic inflammatory reaction by the body. But Pestka’s co-investigator, Jack Harkema, disagrees with this idea. "Cells in the lung can gobble up the silica, but it's so toxic, it usually kills these cells," Harkema said. "When they die, signals are sent out to the immune system that something is wrong. The body then produces such a strong response that it also starts killing healthy cells."

The team didn’t let on the hypothesis they’ll be testing. However, they hope this investigation will shed light on how other respiratory substances can trigger the disease, and what other compounds may quell the lupus reaction.

Additional source: Michigan State University

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
MAY 17, 2021
Cancer
Cells at the center of a tumor are more aggressive and spread faster
MAY 17, 2021
Cells at the center of a tumor are more aggressive and spread faster
New research stemming from a collaboration between researchers from the Francis Crick Institute, Royal Marsden, UCL and ...
MAY 31, 2021
Immunology
Engineering Faster, More Agile T Cell Cancer Fighters
MAY 31, 2021
Engineering Faster, More Agile T Cell Cancer Fighters
Cell therapies use engineered T cells extracted from the patient’s own immune system to rally an attack on tumors. ...
JUN 04, 2021
Cancer
Cancer patients with COVID-19 fare better with remote health monitoring
JUN 04, 2021
Cancer patients with COVID-19 fare better with remote health monitoring
A new study presented last week at the American Society of Clinical Oncology Annual Meeting after its publication in the ...
JUN 22, 2021
Cancer
Evaluating adverse effects of induction therapy for neuroblastoma
JUN 22, 2021
Evaluating adverse effects of induction therapy for neuroblastoma
A study published in the Journal of Clinical Oncology reports an evaluation of the chemotherapy treatment given to child ...
AUG 20, 2021
Drug Discovery & Development
Blood Pressure Drugs Boost Survival in Colorectal Cancer
AUG 20, 2021
Blood Pressure Drugs Boost Survival in Colorectal Cancer
Common drugs used to regulate blood pressure may improve survival rates among patients with colorectal cancer, also know ...
SEP 06, 2021
Drug Discovery & Development
Antibiotics Increase Colon Cancer Risk by 17%
SEP 06, 2021
Antibiotics Increase Colon Cancer Risk by 17%
People who take antibiotics are at an increased risk of developing colon cancer within five to ten years. The research w ...
Loading Comments...